Back to Screener

Healthcare

Patient Portal Technologies, Inc.(PPRG)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+0.00%

Window

Jun 23, 2025 โ†’ Jun 8, 2026

Market Cap
โ€”
Revenue Growth
-10.3%
EPS Growth
-66.7%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 23, 2025 โ†’ Jun 8, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Patient Portal Technologies, Inc. (PPRG) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 8, 2026). Baseline metrics include revenue growth of -10.3%, EPS growth of -66.7%, a dividend yield of 0.0%. What stands out right now is revenue -10.3%, EPS -66.7%, free cash flow -298.1% with operating margin -2.3% and ROIC -3.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PPRG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PPRG

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

PPRG Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PPRG and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Patient Portal Technologies, Inc. (PPRG)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$0.0

-100.0% YoY

FY Net Income

-$131.0K

+67.3% YoY

Free Cash Flow

-$347.3K

+62.3% YoY

Revenue Growth

-10.3%

EPS Growth

-66.7%

Gross Margin

41.5%

Net Margin

-25.3%

Income statement

USD

Annual
Metric20092008200720062005
Revenue16M18M4M14K0
Gross Profit7M7M300K-102K0
Operating Income-376K-202K-2M-275K-105K
EBITDA-1M1M-1M-275K-105K
Net Income-4M-2M-2M-401K-131K
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20092008200720062005
Cash & Equivalents35K411K404K2K1K
Total Assets15M17M15M1M259K
Total Liabilities7M11M7M385K57K
Shareholder Equity8M6M7M717K202K
Total Debt4M6M5M337K337K
Net Debt4M6M5M336K336K

Cash flow positioning

Latest Full Year

Operating Cash Flow

347K

-688.7% YoY

Capital Expenditures

0

+100.0% YoY

Free Cash Flow

347K

+62.3% YoY

Key ratios

  • Gross Margin

    41.5%

  • Operating Margin

    -2.3%

  • Net Margin

    -25.3%

  • ROE

    -57.5%

  • Debt / Equity

    0.47x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.